ArticleslgStudy

chemistry

MDO-NPA

MDO-NPA is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand MDO-NPA rather than just read about it. In short: MDO-NPA (10,11-methylenedioxy-N-n-propylnoraporphine) is a synthetic aporphine derivative used as a research tool in neuropharmacology. It was developed as a methylenedioxy prodrug of N-n-propylnorapomorphine (NPA).

MDO-NPA — main illustration
MDO-NPA — illustration

Key takeaways

  • MDO-NPA belongs to chemistry; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect MDO-NPA to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of MDO-NPA from memory before moving on to harder problems.

Reference excerpt

MDO-NPA (10,11-methylenedioxy-N-n-propylnoraporphine) is a synthetic aporphine derivative used as a research tool in neuropharmacology. It was developed as a methylenedioxy prodrug of N-n-propylnorapomorphine (NPA). A noteworthy advantage that the MDO-NPA congener has over NPA and apomorphine is that MDO-NPA has a high oral bioavailability, whereas the other two do not and must be delivered via subcutaneous injection or intraperitoneally.

Pharmacology

Pharmacokinetics In vivo O-dealkylation releases NPA, yielding an orally effective, relatively long-acting dopaminergic agent that acts at central dopamine receptors. Evidence for this prodrug behavior includes blockade of MDO-NPA’s behavioral effects and prevention of NPA formation by the microsomal oxidase inhibitor SKF-525A.

Pharmacodynamics In animal models, MDO-NPA produces robust dopamine-mediated behavioral effects with “depot-like” properties, and across studies has shown dose-dependent agonist/antagonist interactions and, for certain stereoisomers, limbic-selective actions. MDO-NPA exists as two distinct enantiomers. One of these enantiomers is active as a dopamine agonist while the other is active as a dopamine antagonist. MDO-NPA has not been developed as a therapeutic drug and remains primarily of experimental interest alongside related aporphine congeners.

See also MDMA MDA Propylnorapomorphine UWA-001 Piribedil Anonaine

References

Further reading

Illustrations

MDO-NPA illustration

Worked examples

Example 1 — a first encounter with MDO-NPA

Start with the simplest possible case. Write down what MDO-NPA claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to MDO-NPA before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about MDO-NPA ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of MDO-NPA

In research
MDO-NPA appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses MDO-NPA in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
MDO-NPA is common in secondary-school and first-year university syllabi. It links to neighbouring topics Aporphines, D2 receptor agonists, Heterocyclic compounds with 5 rings, so understanding it makes those chapters shorter.
In everyday life
Look for MDO-NPA outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “MDO-NPA” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study MDO-NPA in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what MDO-NPA means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain MDO-NPA out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is MDO-NPA in simple terms?

MDO-NPA (10,11-methylenedioxy-N-n-propylnoraporphine) is a synthetic aporphine derivative used as a research tool in neuropharmacology. It was developed as a methylenedioxy prodrug of N-n-propylnorapomorphine (NPA).

Why does MDO-NPA matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study MDO-NPA?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on MDO-NPA.

Tags

  • Aporphines
  • D2 receptor agonists
  • Heterocyclic compounds with 5 rings
  • Methylenedioxyphenethylamines

Keep exploring